Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry.
about
Glycan analysis of therapeutic glycoproteinsOptimal Synthetic Glycosylation of a Therapeutic AntibodyOptimal Synthetic Glycosylation of a Therapeutic AntibodyAssessing Analytical Similarity of Proposed Amgen Biosimilar ABP 501 to AdalimumabPepsin-Containing Membranes for Controlled Monoclonal Antibody Digestion Prior to Mass Spectrometry Analysis.Recent advances in the analysis of therapeutic proteins by capillary and microchip electrophoresis.Characterization of N-Linked Glycosylation in a Monoclonal Antibody Produced in NS0 Cells Using Capillary Electrophoresis with Laser-Induced Fluorescence DetectionAnalysis of monoclonal antibody by a novel CE-UV/MALDI-MS interface.Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.Physicochemical characterization of Remsima.Improvement of Mitochondria Extract from Saccharomyces cerevisiae Characterization in Shotgun Proteomics Using Sheathless Capillary Electrophoresis Coupled to Tandem Mass SpectrometryCE-ESI-MS for bottom-up proteomics: Advances in separation, interfacing and applications.Recent advances in combination of capillary electrophoresis with mass spectrometry: methodology and theory.The potential of the capillary electrophoresis techniques for quality control of biopharmaceuticals-a review.Recent developments in capillary and microchip electroseparations of peptides (2013-middle 2015).Cutting-edge mass spectrometry methods for the multi-level structural characterization of antibody-drug conjugates.Differential detection of Rhizoma coptidis by capillary electrophoresis electrospray ionization mass spectrometry with a nanospray interface.Quantitative proteomics using ultralow flow capillary electrophoresis-mass spectrometryCutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies.Rapid level-3 characterization of therapeutic antibodies by capillary electrophoresis electrospray ionization mass spectrometry.Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry.Approval of the first biosimilar antibodies in Europe: a major landmark for the biopharmaceutical industry.Production of highly and broad-range specific monoclonal antibodies against hemagglutinin of H5-subtype avian influenza viruses and their differentiation by mass spectrometry.Novel sheathless CE-MS interface as an original and powerful infusion platform for nanoESI study: from intact proteins to high molecular mass noncovalent complexes.9th annual European Antibody Congress, November 11-13, 2013, Geneva, Switzerland.Detailed mass analysis of structural heterogeneity in monoclonal antibodies using native mass spectrometry
P2860
Q28082842-95B9220C-DDD4-4553-8AF1-BF6357FED90EQ28831266-3C2CD656-503C-43D7-8610-09587775096BQ28831364-428C09EC-ACBE-41FD-B7B2-46E015D67E94Q28831404-E8BF6565-E7DB-45CE-A371-606612320B8FQ30278544-E3E875D3-1A9A-4F46-BCE8-267A5F3EF5AEQ34026046-1665F21C-C3C4-4E90-963D-33FC82A1CB46Q35052763-B118BF63-6716-406D-8849-1C46C20FC166Q35214543-590D0BD4-3038-46C3-A99F-E189A85D916DQ35975965-15247014-62CA-48C7-A5CB-095CF93167B4Q36213623-6969674C-14DB-441F-A2DE-09927EFCF9F8Q36947584-1AB96795-6A1A-491C-90D8-700BF3B71030Q38213808-070DEB07-C87E-40B2-A4A1-7855B52A3096Q38254416-75A351A3-AC94-48C4-ADD7-2AA489FCDD83Q38287278-4520CD59-D88D-4CB8-AE10-B99657DD2B00Q38579040-20B9A244-86BA-4F90-A120-A3C4DBBE8EE6Q38665164-6BF7BB49-106E-46A1-8ED5-47675577132BQ39142148-6613EADA-86C3-4691-B3F6-32BB590A396AQ40388527-F7A0B594-559F-43B5-9080-4E72137523B9Q41177029-ACADD295-D5EC-4FFF-BC78-ED88BA1C2165Q41437299-21B6B0C1-3B7F-4865-A29E-41D998FC6C7BQ41718653-CDBCF3DA-0798-406A-9FF4-25DDAE2968DBQ42846272-AC639055-7E5B-4ECB-B0EE-46B35C8FEE62Q47553484-70D311C6-4275-430A-A98D-E9235F57D0A8Q47947355-F2710A6B-754F-47DA-8F1B-B0F84427E49BQ51238255-C6332BA8-81F8-4B4D-A7D5-51699D46EE07Q57666042-E47B89DA-6BA4-49D0-9D70-158222E7F845
P2860
Rapid and multi-level characterization of trastuzumab using sheathless capillary electrophoresis-tandem mass spectrometry.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Rapid and multi-level characte ...... esis-tandem mass spectrometry.
@en
Rapid and multi-level characte ...... esis-tandem mass spectrometry.
@nl
type
label
Rapid and multi-level characte ...... esis-tandem mass spectrometry.
@en
Rapid and multi-level characte ...... esis-tandem mass spectrometry.
@nl
prefLabel
Rapid and multi-level characte ...... esis-tandem mass spectrometry.
@en
Rapid and multi-level characte ...... esis-tandem mass spectrometry.
@nl
P2093
P2860
P50
P356
P1476
Rapid and multi-level characte ...... resis-tandem mass spectrometry
@en
P2093
Alain Beck
Alicia Burr
Lauriane Kuhn
Phillipe Hammann
P2860
P304
P356
10.4161/MABS.23995
P577
2013-04-05T00:00:00Z